|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 303-313, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
PL Julia, GD Buckberg, C Acar, MT Partington and MP Sherman
Postischemic damage is caused partially by oxygen free radical-mediated
injury. This study will show that (1) crystalloid cardioplegia with room
air oxygen is deleterious because it is devoid of free radical scavengers
and (2) blood cardioplegia limits damage because it contains endogenous
free radical scavengers in red blood cells. METHODS: Thirty- two dogs
underwent 2 hours of ligation of the left anterior descending coronary
artery followed by 20 minutes of regional blood cardioplegic reperfusion on
bypass. Ten dogs received only the blood cardioplegic solution (containing
its endogenous free radical scavengers); five received initial blood
cardioplegia (5 minutes) with endogenous free radical scavengers (catalase
and glutathione peroxidase) blocked by aminotriazole and N-ethylmaleimide,
respectively; 12 received initial crystalloid cardioplegic solution
oxygenated by room air (oxygen tension = 150 mm Hg); seven without and five
with exogenous free radical scavengers (superoxide dismutase, catalase,
coenzyme Q10); five received initial deoxygenated crystalloid cardioplegic
solution (oxygen tension = 6 mm Hg); and five received deoxygenated
crystalloid cardioplegic solution. RESULTS: Blood cardioplegia with
endogenous free radical scavengers produced the best recovery of systolic
shortening (69% systolic shortening) and resulted in the least
histochemical damage (11% triphenyltetrazolium chloride nonstaining). The
worst recovery and most damage occurred if blood cardioplegia was preceded
by oxygenated crystalloid cardioplegia (3% systolic shortening, 48%
triphenyltetrazolium chloride nonstaining; p less than 0.05 versus blood
cardioplegia) or if free radical scavengers were blocked in the initial
period of blood cardioplegia (3% systolic shortening, 41%
triphenyltetrazolium chloride nonstaining; p less than 0.05 versus blood
cardioplegia). Conversely, deoxygenation or supplementation of oxygenated
crystalloid cardioplegic solution with exogenous free radical scavengers
restored 60% systolic shortening (p less than 0.05 versus oxygenated
crystalloid cardioplegia) and 54% systolic shortening (p less than 0.05
versus oxygenated crystalloid cardioplegia) and reduced damage to 34% and
21% (both p less than 0.05 versus oxygenated crystalloid cardioplegia).
CONCLUSION: Blood cardioplegic solutions containing their own endogenous
free radical scavengers are superior to crystalloid cardioplegic solutions,
because they limit oxygen-mediated perfusion damage and restore contractile
function. Initial crystalloid cardioplegic washout negates the salutary
effect of blood cardioplegia. Exogenous free radical scavenger
supplementation or deoxygenation of the cardioplegic reperfusate is
necessary only if crystalloid cardioplegia is used.
ARTICLES
Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells
Department of Surgery, University of California, Los Angeles School of Medicine 90024-1741.
This article has been cited by other articles:
![]() |
M. L. Fontes, S. Aronson, J. P. Mathew, Y. Miao, B. Drenger, P. G. Barash, D. T. Mangano, For the Multicenter Study of Perioperative Ischemi, and the Ischemia Research and Education Foundation (IR Pulse Pressure and Risk of Adverse Outcome in Coronary Bypass Surgery Anesth. Analg., October 1, 2008; 107(4): 1122 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bezon, J. N. Choplain, A. A. Aziz Khalifa, H. Numa, N. Salley, and J. A. Barra Continuous retrograde blood cardioplegia ensures prolonged aortic cross-clamping time without increasing the operative risk Interact CardioVasc Thorac Surg, August 1, 2006; 5(4): 403 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ott, N. A. Nussmeier, P. C. Duke, R. O. Feneck, R. P. Alston, M. C. Snabes, R. C. Hubbard, P. H. Hsu, L. J. Saidman, and D. T. Mangano Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1481 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chocron, K. Alwan, Y. Yan, G. Toubin, D. Kaili, T. Anguenot, L. Latini, F. Clement, J.-F. Viel, and J.-P. Etievent Warm reperfusion and myocardial protection Ann. Thorac. Surg., December 1, 1998; 66(6): 2003 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lindner, S. Ismail, W. D. Spotnitz, D. M. Skyba, A. R. Jayaweera, and S. Kaul Albumin Microbubble Persistence During Myocardial Contrast Echocardiography Is Associated With Microvascular Endothelial Glycocalyx Damage Circulation, November 17, 1998; 98(20): 2187 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tofukuji, A. Stamler, J. Li, M. D. Hariawala, A. Franklin, and F. W. Sellke Comparative Effects of Continuous Warm Blood and Intermittent Cold Blood Cardioplegia on Coronary Reactivity Ann. Thorac. Surg., November 1, 1997; 64(5): 1360 - 1367. [Abstract] [Full Text] |
||||
![]() |
M. S. Bayfield, J. R. Lindner, S. Kaul, S. Ismail, M. L. K. Sheil, N. C. Goodman, R. Zacour, and W. D. Spotnitz DEOXYGENATED BLOOD MINIMIZES ADHERENCE OF SONICATED ALBUMIN MICROBUBBLES DURING CARDIOPLEGIC ARREST AND AFTER BLOOD REPERFUSION: EXPERIMENTAL AND CLINICAL OBSERVATIONS WITH MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1100 - 1108. [Abstract] [Full Text] |
||||
![]() |
J. C. Cleveland Jr, D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken Optimal Myocardial Preservation: Cooling, Cardioplegia, and Conditioning Ann. Thorac. Surg., February 1, 1996; 61(2): 760 - 768. [Abstract] [Full Text] |
||||
![]() |
J. R. Pepper, S. Mumby, and J. M. C. Gutteridge Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypass Ann. Thorac. Surg., December 1, 1995; 60(6): 1735 - 1740. [Abstract] [PDF] |
||||
![]() |
E. R. Rosenkranz Substrate enhancement of cardioplegic solution: Experimental studies and clinical evaluation Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800. [Abstract] [PDF] |
||||
![]() |
R. T. Smolenski, A.-M. L. Seymour, and M. H. Yacoub Dynamics of energy metabolism in the transplanted human heart during reperfusion J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 938 - 945. [Abstract] [Full Text] |
||||
![]() |
B. Biagioli, P. Giomarelli, G. Gnudi, E. Artioli, F. Simeone, G. Paolini, L. Marchetti, and A. Grossi Myocardial function in early hours after coronary artery bypass grafting: Comparison of two cardioplegic methods Ann. Thorac. Surg., December 1, 1993; 56(6): 0003497593906725 - 3497593906725. [Abstract] [PDF] |
||||
![]() |
F. W. Sellke, T. Shafique, R. G. Johnson, H. B. Dai, P. F. Banitt, F. J. Schoen, and R. M. Weintraub Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses Ann. Thorac. Surg., April 1, 1993; 55(4): 977 - 985. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |